![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1-chloro-2,4-dinitrobenzene | affects binding | ISO | RGD:1314598 | 6480464 | Dinitrochlorobenzene binds to ECPAS protein | CTD | PMID:32991956 | 17beta-estradiol | affects expression | ISO | RGD:1314598 | 6480464 | Estradiol affects the expression of ECPAS mRNA | CTD | PMID:14699072 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | RGD:1314599 | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ECPAS mRNA | CTD | PMID:34747641 | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:1314598 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased expression of ECPAS protein | CTD | PMID:34186270 | acrolein | multiple interactions | ISO | RGD:1314598 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ECPAS mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ECPAS mRNA | CTD | PMID:32699268 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of ECPAS mRNA | CTD | PMID:28959563 | all-trans-retinoic acid | decreases expression | ISO | RGD:1314598 | 6480464 | Tretinoin results in decreased expression of ECPAS mRNA | CTD | PMID:23724009, PMID:33167477 | alpha-pinene | multiple interactions | ISO | RGD:1314598 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ECPAS mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ECPAS mRNA | CTD | PMID:32699268 | amiodarone | decreases expression | EXP | | 6480464 | Amiodarone results in decreased expression of ECPAS mRNA | CTD | PMID:17991464 | antirheumatic drug | increases expression | ISO | RGD:1314598 | 6480464 | Antirheumatic Agents results in increased expression of ECPAS mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | RGD:1314598 | 6480464 | aristolochic acid I results in decreased expression of ECPAS mRNA | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | RGD:1314598 | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to ECPAS mRNA] | CTD | PMID:32406909 | arsenous acid | increases expression | ISO | RGD:1314598 | 6480464 | Arsenic Trioxide results in increased expression of ECPAS mRNA | CTD | PMID:20458559 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of ECPAS mRNA | CTD | PMID:21839799 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ECPAS mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | RGD:1314598 | 6480464 | bisphenol A results in increased expression of ECPAS protein | CTD | PMID:34186270 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ECPAS mRNA | CTD | PMID:34947998 | bisphenol A | affects expression | ISO | RGD:1314598 | 6480464 | bisphenol A affects the expression of ECPAS mRNA | CTD | PMID:30903817 | Bisphenol B | increases expression | ISO | RGD:1314598 | 6480464 | bisphenol B results in increased expression of ECPAS protein | CTD | PMID:34186270 | bortezomib | increases expression | ISO | RGD:1314598 | 6480464 | Bortezomib results in increased expression of ECPAS mRNA | CTD | PMID:20977926 | butanal | decreases expression | ISO | RGD:1314598 | 6480464 | butyraldehyde results in decreased expression of ECPAS mRNA | CTD | PMID:26079696 | chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of ECPAS mRNA | CTD | PMID:23125180 | chlorpyrifos | decreases expression | ISO | RGD:1314599 | 6480464 | Chlorpyrifos results in decreased expression of ECPAS mRNA | CTD | PMID:37019170 | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of ECPAS mRNA | CTD | PMID:24386269 | copper(II) sulfate | increases expression | ISO | RGD:1314598 | 6480464 | Copper Sulfate results in increased expression of ECPAS mRNA | CTD | PMID:19549813 | crocidolite asbestos | increases expression | ISO | RGD:1314598 | 6480464 | Asbestos, Crocidolite results in increased expression of ECPAS mRNA | CTD | PMID:29523930 | crocidolite asbestos | decreases expression | ISO | RGD:1314599 | 6480464 | Asbestos, Crocidolite results in decreased expression of ECPAS mRNA | CTD | PMID:29279043 | cyclosporin A | increases expression | ISO | RGD:1314598 | 6480464 | Cyclosporine results in increased expression of ECPAS mRNA | CTD | PMID:20106945, PMID:25562108 | dextran sulfate | decreases expression | ISO | RGD:1314599 | 6480464 | Dextran Sulfate results in decreased expression of ECPAS protein | CTD | PMID:32272095 | dextran sulfate | multiple interactions | ISO | RGD:1314599 | 6480464 | Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ECPAS protein] | CTD | PMID:32272095 | diarsenic trioxide | increases expression | ISO | RGD:1314598 | 6480464 | Arsenic Trioxide results in increased expression of ECPAS mRNA | CTD | PMID:20458559 | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of ECPAS mRNA | CTD | PMID:21658437 | dorsomorphin | multiple interactions | ISO | RGD:1314598 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | entinostat | decreases expression | ISO | RGD:1314598 | 6480464 | entinostat results in decreased expression of ECPAS mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | RGD:1314598 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECPAS mRNA | CTD | PMID:27188386 | enzyme inhibitor | multiple interactions | ISO | RGD:1314598 | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ECPAS protein | CTD | PMID:23301498 | ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of ECPAS protein | CTD | PMID:19609968 | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of ECPAS mRNA | CTD | PMID:24136188 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of ECPAS mRNA | CTD | PMID:24136188 | ivermectin | decreases expression | ISO | RGD:1314598 | 6480464 | Ivermectin results in decreased expression of ECPAS protein | CTD | PMID:32959892 | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of ECPAS mRNA | CTD | PMID:24136188 | menadione | affects expression | ISO | RGD:1314598 | 6480464 | Vitamin K 3 affects the expression of ECPAS mRNA | CTD | PMID:20044591 | methylmercury chloride | increases expression | ISO | RGD:1314598 | 6480464 | methylmercuric chloride results in increased expression of ECPAS mRNA | CTD | PMID:28001369 | methylmercury chloride | decreases expression | ISO | RGD:1314598 | 6480464 | methylmercuric chloride results in decreased expression of ECPAS mRNA | CTD | PMID:28001369 | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of ECPAS mRNA | CTD | PMID:24136188 | nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of ECPAS mRNA | CTD | PMID:24136188 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of ECPAS mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | RGD:1314598 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ECPAS mRNA more ... | CTD | PMID:32699268 | panobinostat | multiple interactions | ISO | RGD:1314598 | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECPAS mRNA | CTD | PMID:27188386 | panobinostat | decreases expression | ISO | RGD:1314598 | 6480464 | panobinostat results in decreased expression of ECPAS mRNA | CTD | PMID:26272509 | pentanal | decreases expression | ISO | RGD:1314598 | 6480464 | pentanal results in decreased expression of ECPAS mRNA | CTD | PMID:26079696 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | RGD:1314599 | 6480464 | perfluorooctane sulfonic acid results in decreased expression of ECPAS protein | CTD | PMID:26178269 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | RGD:1314599 | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ECPAS mRNA | CTD | PMID:36331819 | perfluorooctanoic acid | increases expression | ISO | RGD:1314598 | 6480464 | perfluorooctanoic acid results in increased expression of ECPAS protein | CTD | PMID:26879310 | phenylmercury acetate | decreases expression | ISO | RGD:1314598 | 6480464 | Phenylmercuric Acetate results in decreased expression of ECPAS mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:1314598 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECPAS mRNA | CTD | PMID:27188386 | resveratrol | multiple interactions | ISO | RGD:1314598 | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of ECPAS mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | ISO | RGD:1314598 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sunitinib | increases expression | ISO | RGD:1314598 | 6480464 | Sunitinib results in increased expression of ECPAS mRNA | CTD | PMID:31533062 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of ECPAS mRNA | CTD | PMID:31150632 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of ECPAS mRNA | CTD | PMID:25729387 | trichostatin A | decreases expression | ISO | RGD:1314598 | 6480464 | trichostatin A results in decreased expression of ECPAS mRNA | CTD | PMID:24935251 | trichostatin A | affects expression | ISO | RGD:1314598 | 6480464 | trichostatin A affects the expression of ECPAS mRNA | CTD | PMID:28542535 | trichostatin A | increases expression | ISO | RGD:1314598 | 6480464 | trichostatin A results in increased expression of ECPAS mRNA | CTD | PMID:24935251 | valdecoxib | increases expression | EXP | | 6480464 | valdecoxib results in increased expression of ECPAS mRNA | CTD | PMID:24136188 | valproic acid | increases methylation | ISO | RGD:1314598 | 6480464 | Valproic Acid results in increased methylation of ECPAS gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | RGD:1314598 | 6480464 | Valproic Acid affects the expression of ECPAS mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | RGD:1314598 | 6480464 | Valproic Acid results in decreased expression of ECPAS mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | RGD:1314598 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECPAS mRNA | CTD | PMID:27188386 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of ECPAS mRNA | CTD | PMID:20566332 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of ECPAS mRNA | CTD | PMID:18042343 | |